JenaValve

Edwards Lifesciences

MedTech

Edwards inks $1.6B in deals for JenaValve, Endotronix

With $1.2 billion split in upfront cash, Edwards will gain JenaValve's aortic regurgitation valve and Endotronix's heart failure monitor.

Conor Hale Jul 25, 2024 11:00am

heart model heart disease

JenaValve nabs $100M to clear TAVR system’s FDA pathway

Aug 31, 2022 3:35pm

Red blood cells

TAVR developer JenaValve nets $50M from Bain Capital

Feb 7, 2020 10:25am